Advanced Non-Squamous and Squamous NSCLC Market is segmented By Molecule Type (Monoclonal antibody, Small molecule, Peptide), By Treatment (Immunotherapy, Chemotherapy), By Disease (Non-Squamous Cell Carcinoma, Squamous Cell Carcinoma), By Route of Administration (Oral, Subcutaneous, Intravitreal, Intramuscular), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.
The major players operating in the advanced non-squamous and squamous NSCLC market include AstraZeneca, Roche, Novartis, Pfizer, Bristol-Myers Squibb, Jiangsu Alphamab Biopharmaceuticals, and Jiangsu HengRui Medicine.
Advanced Non-Squamous and Squamous NSCLC Market